Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 78.46B P/E 50.78 EPS this Y 6.00% Ern Qtrly Grth -44.80%
Income 1.26B Forward P/E 20.09 EPS next Y 10.80% 50D Avg Chg 7.00%
Sales 19.49B PEG 2.16 EPS past 5Y 1.39% 200D Avg Chg 11.00%
Dividend 1.00% Price/Book 3.05 EPS next 5Y 8.65% 52W High Chg -4.00%
Recommedations 1.90 Quick Ratio 0.46 Shares Outstanding 288.90M 52W Low Chg 28.00%
Insider Own 0.31% ROA 3.12% Shares Float 288.21M Beta 0.45
Inst Own 89.32% ROE 5.13% Shares Shorted/Prior 2.79M/2.47M Price 276.24
Gross Margin 44.72% Profit Margin 6.44% Avg. Volume 1,216,300 Target Price 278.54
Oper. Margin 10.69% Earnings Date May 2 Volume 1,396,333 Change -0.83%
About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Becton, Dickinson and Company News
03/27/24 New Survey Reveals Patients Receive Too Many Needlesticks
03/26/24 BD Named Among Fortune's Most Innovative Companies
03/25/24 QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness
03/21/24 UPDATE 3-Becton Dickinson ramps up syringe production in US amid China quality concerns
03/21/24 BD Increases Domestic Production to Support U.S. Health Care Need for Syringes
03/19/24 Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
03/18/24 BD and Health Care Consortium in Denmark Find Success in Medical Waste Recycling Study
03/14/24 BD's (BDX) ADC System Favored by New Study for Long-Term Care
03/13/24 7 Robotic Surgery Stocks to Buy for the Future of Healthcare
03/13/24 New Study Highlights Benefits of Medication Management Automation in Long-Term Care Facilities
03/12/24 Here's Why You Should Retain BD (BDX) to Your Portfolio
03/06/24 Becton Dickinson & Co's Dividend Analysis
03/05/24 BD (BDX) Initiates IDE Study to Aid Treatment of Artery Disease
03/04/24 3 Stocks to Buy at 52-Week Lows: March 4 Edition
03/04/24 Becton, Dickinson and Company (BDX) Fell on Lower-Than-Expected 2024 Guidance
03/04/24 BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease
03/02/24 Should You Buy Becton, Dickinson and Company (NYSE:BDX) For Its Upcoming Dividend?
02/29/24 Becton, Dickinson and Company (BDX) Faced Macroeconomic Headwinds in Q4
02/27/24 Get Paid While You Wait: 7 Dividend Aristocrats to Buy Now
02/27/24 Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
BDX Chatroom

User Image StockInvest_us Posted - 10 hours ago

Signal alert: $BDX - GoldenStar https://stockinvest.us/l/xPz8BS0Jpm

User Image Greenleaf20 Posted - 12 hours ago

$BDX breaking out to 260

User Image StockInvest_us Posted - 1 day ago

Signal alert: $BDX - GoldenStar https://stockinvest.us/l/G8nVMvgbyE

User Image RiskVsReward Posted - 5 days ago

A true thing of beauty.. $BDX

User Image TalkMarkets Posted - 5 days ago

Becton, Dickinson And Co. Dividend Stock Analysis $BAX $BDX $MDT https://talkmarkets.com/content/stocks--equities/becton-dickinson-and-co-dividend-stock-analysis?post=438065

User Image StockInvest_us Posted - 5 days ago

Signal alert: $BDX - Double Bottom https://stockinvest.us/l/GC46dDbemN

User Image JackDarwin Posted - 5 days ago

$BDX Bullish Gap Up With High Volume.

User Image ca_rott1487 Posted - 6 days ago

$BDX settled $85M with investors to end litigation over software errors with Alaris infusion pumps. Claim submission info and details:https://11thestate.com/cases/bdx-shareholder-settlement

User Image DonCorleone77 Posted - 1 week ago

$BDX Becton Dickinson further increases U.S. syringe production Becton Dickinson issued the following statement regarding the March 19 FDA Safety Communication, which provided updates on FDA's ongoing evaluation of certain plastic syringes: Eric Borin, president of BD Medication Delivery Solutions said, "BD has the capacity to support additional syringe demand and is further increasing U.S. production to help ensure continuity of patient care. Since the initial FDA safety communication in November, BD has increased domestic manufacturing of syringes in our Nebraska and Connecticut facilities to respond to customer needs. Ensuring the safety and quality of our products is the top priority at BD. The latest FDA safety communication does not include any BD syringes. Over our more than 125-year history, we have served the health care system's need for essential high quality medical products, including manufacturing 2 billion additional syringes and needles...."

User Image Stock_Titan Posted - 1 week ago

$BDX BD Increases Domestic Production to Support U.S. Health Care Need for Syringes https://www.stocktitan.net/news/BDX/bd-increases-domestic-production-to-support-u-s-health-care-need-for-ikpkb10qdrjc.html

User Image Zit1343 Posted - 1 week ago

$BDX watch out for 20 sma breakout Prdgx

User Image Stock_Titan Posted - 1 week ago

$BDX BD and Health Care Consortium in Denmark Find Success in Medical Waste Recycling Study https://www.stocktitan.net/news/BDX/bd-and-health-care-consortium-in-denmark-find-success-in-medical-syrcm2i4n4s9.html

User Image liability1 Posted - 1 week ago

$AXDX $BDX hey whiskey bacon arc is approved and I will give you some more info but feel free to go on the new accelerate website and it will show you everything and mention the collaboration with Becton Dickinson note that the website was just redone so if you looked at it a couple days or weeks ago, you would not have seen what you see now it’s pretty amazingclick on the videos and since they already put arc on their website for distribution take my word for granted that the FDA approved it they most likely will announce it on the 28th this month

User Image QuiverQuant Posted - 1 week ago

CONGRESSIONAL TRADING: Senator Capito, Shelley Moore disclosed a sale (full) of $1,001 - $15,000 of $BDX on 2024-03-15.

User Image Esau815 Posted - 1 week ago

$AXDX Something potentially troubling on the $BDX front. See where their head of Life Science Division is retiring July 1. That's the Division that would encompass Wave. Successor hasn't been named. Clinical trials complete just around then. Will a new guy/woman be willing to pull the trigger so quickly?

User Image insiderbuyingselling Posted - 1 week ago

$BDX new insider selling: 282 shares. http://insiderbuyingselling.com/?t=BDX

User Image QuiverQuant Posted - 1 week ago

CONGRESSIONAL TRADING: Senator Capito, Shelley Moore disclosed a sale (full) of $1,001 - $15,000 of $BDX on 2024-03-15.

User Image QuiverQuant Posted - 1 week ago

CONGRESSIONAL TRADING: Senator Capito, Shelley Moore disclosed a sale (full) of $1,001 - $15,000 of $BDX on 2024-03-15.

User Image WHISKEYBACON Posted - 1 week ago

$AXDX $BDX so where does Wave and partnership with both Bruker and BD fit in European hospitals. Read article . @AXDX say something soon please https://news.bd.com/2024-03-14-BD-Collaborates-with-GOCC-to-Combat-Sepsis-in-Poland

User Image Stock_Titan Posted - 1 week ago

$BDX Zeus Names New Chief Executive Officer https://www.stocktitan.net/news/BDX/zeus-names-new-chief-executive-ygis9rv19xo1.html

User Image ca_rott1487 Posted - 2 weeks ago

$BDX settled $85M with investors to end litigation over software errors with Alaris infusion pumps. You can file for this compensation here. CasePage:https://11thestate.com/cases/bdx-shareholder-settlement

User Image ksoption Posted - 2 weeks ago

$BDX

User Image Stock_Titan Posted - 2 weeks ago

$BDX New Study Highlights Benefits of Medication Management Automation in Long-Term Care Facilities https://www.stocktitan.net/news/BDX/new-study-highlights-benefits-of-medication-management-automation-in-e9j26589hc8i.html

User Image StockInvest_us Posted - 2 weeks ago

Signal alert: $BDX - GoldenStar https://stockinvest.us/l/afsBWH867H

User Image StockInvest_us Posted - 2 weeks ago

Signal alert: $BDX - Double Bottom https://stockinvest.us/l/9I1C1enc9I

User Image swingingtech Posted - 3 weeks ago

$PRGO $BDX $FAF https://wallstreetwaves.com/ex-dividend-reminder-perrigo-company-becton-dickinson-and-first-american-financial/

User Image swingingtech Posted - 3 weeks ago

$BDX $CAH https://wallstreetwaves.com/bd-bdx-initiates-ide-study-to-aid-treatment-of-artery-disease/

User Image StockInvest_us Posted - 3 weeks ago

Signal alert: $BDX - PivotPoint bottom https://stockinvest.us/l/MsNy074ge9

User Image Stock_Titan Posted - 3 weeks ago

$BDX BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease https://www.stocktitan.net/news/BDX/bd-initiates-international-study-to-expand-treatment-options-for-mf7wl6xdoroh.html

User Image etradebaby Posted - 3 weeks ago

$BDX solid! (not solid)

Analyst Ratings
Barclays Overweight Feb 5, 24
Raymond James Outperform Jan 3, 24
Morgan Stanley Overweight Dec 4, 23
Piper Sandler Overweight Nov 10, 23
Raymond James Outperform Nov 10, 23
Citigroup Neutral Aug 21, 23
Barclays Overweight Aug 7, 23
Morgan Stanley Overweight Aug 4, 23
Raymond James Outperform Aug 4, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Byrd Richard EVP & President Inte.. EVP & President Interventional Nov 28 Sell 238.47 2,156 514,141 4,120 11/29/23
Byrd Richard EVP & President Inte.. EVP & President Interventional Sep 05 Sell 274.48 459 125,986 3,444 09/06/23
Fraser Claire Director Director Aug 28 Sell 281.66 848 238,848 21,608 08/30/23
Garrison Michael David EVP & President Medi.. EVP & President Medical Aug 08 Sell 277.13 1,300 360,269 5,157 08/09/23
Goette Roland EVP and President, E.. EVP and President, EMEA Nov 16 Option 74.94 4,617 345,998 14,896 11/18/22
Hickey David EVP & President, Lif.. EVP & President, Life Sciences Aug 15 Sell 265.00 475 125,875 3,331 08/17/22
Polen Thomas E Jr Chairman, CEO and Pr.. Chairman, CEO and President Aug 15 Option 167.91 15,000 2,518,650 43,878 08/17/22
Polen Thomas E Jr Chairman, CEO and Pr.. Chairman, CEO and President Aug 15 Sell 265.13 9,500 2,518,735 28,878 08/17/22
Spoerel Thomas J VP Controller & Chie.. VP Controller & Chief Acct Off Jun 07 Sell 260 443 115,180 1,058 06/09/22
Spoerel Thomas J VP Controller & Chie.. VP Controller & Chief Acct Off Jun 07 Option 147.68 1,026 151,520 2,070 06/09/22
Hickey David EVP & President, Lif.. EVP & President, Life Sciences May 06 Sell 256 475 121,600 3,806 05/10/22
Larson Betty D EVP HR & CHRO EVP HR & CHRO Feb 25 Option 193.09 46,658 9,009,193 9,556 02/28/22
Larson Betty D EVP HR & CHRO EVP HR & CHRO Feb 25 Sell 271.9 14,374 3,908,291 5,872 02/28/22
Fraser Claire Director Director Feb 08 Sell 271.70 841 228,500 21,556 02/10/22
Conroy Alexandre EVP of Integrated Su.. EVP of Integrated Supply Chain Feb 03 Option 134.73 12,787 1,722,793 34,047 02/07/22
Conroy Alexandre EVP of Integrated Su.. EVP of Integrated Supply Chain Feb 03 Sell 270.16 6,410 1,731,726 21,260 02/07/22
Lim James C Executive Vice Presi.. Executive Vice President Sep 07 Sell 257.44 6,956 1,790,753 19,768 09/07/21
Lim James C Executive Vice Presi.. Executive Vice President Sep 07 Option 134.73 14,584 1,964,902 34,352 09/07/21